Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action

1983/06/01 by Charles H. Chesnut, Joel L. Ivey, Helen E. Gruber +4 · 4 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Anabolism #Bone decalcification #Bone health and osteoporosis research #Bone mineral #Calcium #Endocrinology #Estrogen and related hormone effects #Internal medicine #Medicine #Menopause: Health Impacts and Treatments #Osteoporosis #Pathology #Placebo #Postmenopausal osteoporosis #Stanozolol #Urinary calcium #Urinary system #Urology

paper · doi:10.1016/0026-0495(83)90027-6

openalex publication_date 1983/06/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Cited by

• Is dehydroepiandrosterone a hormone?
• A validated stability-indicating TLC-densitometric method for the determination of stanozolol in pharmaceutical formulations. [europepmc]
• Effects of stanozolol on normal and IL-1β-stimulated equine chondrocytes in vitro. [europepmc]
• Medicinal Use of Testosterone and Related Steroids Revisited. [europepmc]